Keyphrases
COVID-19
100%
Indonesia
99%
Tuberculosis Patients
74%
Surabaya
62%
Pulmonary Tuberculosis
53%
Multidrug-resistant Tuberculosis (MDR-TB)
50%
Tuberculosis
38%
COVID-19 Patients
34%
Sargassum
32%
Meta-analysis
31%
Seaweed
27%
Mycobacterium Tuberculosis (M. tb)
27%
Asthma
22%
Systematic Meta-analysis
22%
Indonesian
20%
Sputum
20%
Risk Factors
20%
Healthcare Workers
19%
Acid-fast Bacilli
18%
Community-acquired Pneumonia
18%
TB Patients
18%
East Java Indonesia
17%
Idiopathic Pulmonary Fibrosis
15%
Eucheuma Cottonii
15%
Rifampicin
15%
Sargassum Duplicatum
14%
Chronic Obstructive Pulmonary Disease
13%
Flour
13%
Core Needle Biopsy
13%
Fucoxanthin
12%
Tertiary Referral Hospital
12%
Electronic Nose (E-nose)
12%
Bedaquiline
12%
Lung Tissue
12%
Chest X-ray
11%
Active Tuberculosis
11%
Alginate
11%
General Hospital
11%
Tuberculosis Treatment
11%
Hypertension
11%
Type 1 Diabetes Mellitus (T1DM)
11%
Disease Severity
10%
Acute Respiratory Distress Syndrome
10%
Medical Records
10%
Mortality Risk
10%
Carrageenan
10%
COVID-19 Vaccine
10%
Treatment Group
9%
Diabetic Mice
9%
Rifampicin-resistant Tuberculosis
9%
Interleukin-6
9%
Antioxidant Activity
9%
Academic Hospital
9%
Antibody Response
9%
Modified Starch
9%
Commercial Feed
9%
Lopinavir
9%
Bruguiera Gymnorrhiza
9%
Shorter Regimen
9%
Severe Coronavirus Disease 2019
8%
Intensive Phase
8%
Mortality Rate
8%
GeneXpert
8%
Pneumonia Patients
8%
Adverse Effects
8%
Serum Levels
8%
QT Prolongation
8%
C-reactive Protein
8%
Immune Response
8%
N-acetyltransferase 2 (NAT2)
8%
Artemia
8%
Breast Cancer
8%
Survival Rate
8%
Anti-tuberculosis Drugs
8%
Quality of Life
8%
Inflammatory Cytokines
8%
Lung Cancer
8%
Hospitalized Patients
7%
Kappaphycus Alvarezii
7%
Antioxidant
7%
Tuberculosis Diagnosis
7%
Pulmonary Fibrosis
7%
Armpit
7%
Bronchodilator
7%
Treatment Outcome
7%
Sputum Samples
7%
Body Mass Index
7%
QTc Interval
7%
Immunohistochemistry
7%
Mortality Prediction
7%
Moxifloxacin
7%
Completely Randomized Design
7%
Culture Method
7%
Growth Rate
7%
Bioplastics
7%
Pleural Fluid
7%
Microalgae
7%
Quantitative PCR
6%
Wound Healing Process
6%
Comorbidity
6%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
72%
Coronavirinae
49%
Lung Tuberculosis
45%
Infection
31%
Sargassum
27%
Rifampicin
23%
Asthma
23%
Multi-Drug-Resistant Tuberculosis
22%
Diabetes Mellitus
21%
Symptom
19%
Drug Resistant Tuberculosis
18%
SARS Coronavirus
17%
Mouse
17%
Side Effect
16%
Antioxidant
15%
Community Acquired Pneumonia
15%
Tumor Necrosis Factor
15%
Tuberculosis
14%
Chronic Obstructive Lung Disease
13%
COVID-19 Vaccine
13%
Mortality Rate
13%
Breast Cancer
13%
Prevalence
12%
Mycobacterium Tuberculosis
12%
Wound Healing
12%
Bedaquiline
12%
Vaccination Policy
12%
Retrospective Study
11%
Acid Fast Bacterium
11%
Interleukin 6
11%
Adult Respiratory Distress Syndrome
10%
Antibiotics
10%
Cross-Sectional Study
9%
Non Small Cell Lung Cancer
9%
Okra
9%
Alginic Acid
9%
Fibrosing Alveolitis
9%
Lopinavir Plus Ritonavir
9%
Randomized Controlled Trial
8%
Disease Severity
8%
Adverse Event
8%
C Reactive Protein
8%
Inflammation
8%
Bronchodilating Agent
7%
Moxifloxacin
7%
Lung Cancer
7%
Biological Marker
7%
Antioxidant Capacity
7%
Tuberculostatic Agent
7%
Comorbidity
7%
Bagg Albino Mouse
7%
Cytokine
6%
Lung Fibrosis
6%
Cohort Study
6%
Neoplasm
6%
Quinolone Derivative
6%
Adenosine Deaminase
6%
Fucoxanthin
6%
Latent Tuberculosis
6%
Liver Injury
6%
Salbutamol
6%
Adenosine Receptor
6%
Aminophylline
6%
Electrolyte Disturbance
6%
Extrapulmonary Tuberculosis
6%
Combination Drug
6%
Hydroxychloroquine
6%
Pharmacokinetics
6%
Isoniazid
6%
Cytokine Storm
5%
Injury
5%
Azithromycin
5%
IC50
5%
Atypical Mycobacterium
5%
Mycobacteria
5%
Antivirus Agent
5%
Pharmacotherapy
5%
Medicine and Dentistry
COVID-19
87%
Lung Tuberculosis
36%
Sputum
26%
Infection
23%
Disease
23%
Biopsy
17%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Systematic Review
15%
Multidrug Resistant Tuberculosis
15%
Acid Fast Bacterium
13%
Meta-Analysis
13%
Community-Acquired Pneumonia
12%
Symptom
11%
Prevalence
10%
COVID-19 Vaccine
10%
Lung Tumor
9%
Mortality Rate
9%
Drug Resistant Tuberculosis
9%
Idiopathic Pulmonary Fibrosis
9%
Sweat
9%
Lymphocyte
9%
Chest Radiograph
9%
Cross Sectional Study
8%
Mycobacterium Tuberculosis
8%
Retrospective Study
8%
Randomized Controlled Trial
8%
Interleukin 6
7%
Extrapulmonary Tuberculosis
7%
Immunohistochemistry
7%
Tuberculosis
7%
Tuberculostatic Agent
7%
Tumor Necrosis Factor
7%
Patient Referral
7%
Mixed Infection
7%
Biological Marker
6%
Immune Response
6%
Drug Therapy
6%
Malignant Neoplasm
6%
Asthma
6%
Diabetes Mellitus
6%
Rifampicin
6%
Non Small Cell Lung Cancer
6%
Adenosine Deaminase
6%
Antibody Response
6%
Liver Injury
6%
Acute Respiratory Distress Syndrome
6%
Non-Hodgkin Lymphoma
6%
Diagnosis
6%
Adverse Event
6%
Antibiotics
5%
Medical Record
5%
Artificial Respiration
5%
COVID-19 Vaccination
5%
Neutrophil
5%
Polymerase Chain Reaction
5%